Fowler, D. H., Mossoba, M. E., Steinberg, S. M., Halverson, D. C., Stroncek, D., Khuu, H. M., . . . Bishop, M. R. (2013). Phase 2 clinical trial of rapamycin-resistant donor CD4(+) Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. American Society of Hematology.
Citación estilo ChicagoFowler, Daniel H., et al. Phase 2 Clinical Trial of Rapamycin-resistant Donor CD4(+) Th2/Th1 (T-Rapa) Cells After Low-intensity Allogeneic Hematopoietic Cell Transplantation. American Society of Hematology, 2013.
Cita MLAFowler, Daniel H., et al. Phase 2 Clinical Trial of Rapamycin-resistant Donor CD4(+) Th2/Th1 (T-Rapa) Cells After Low-intensity Allogeneic Hematopoietic Cell Transplantation. American Society of Hematology, 2013.